STOCK TITAN
  1. Home
  2. Sec-filings
  3. NTRA
  4. [Form 4] Natera, Inc. Insider Trading Activity

Natera, Inc. (NTRA) CFO disposes of 5,064 shares in 10b5-1 trades

Filing Impact
(Very High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Natera, Inc.’s Chief Financial Officer, Brophy Michael Burkes, reported open-market sales of 5,064 shares of common stock on July 27–29, 2026. Individual trades ranged from 170 to 1,863 shares, with reported prices such as $260.4908 and $249.3800 per share. Certain sales were executed to satisfy tax withholding from vesting RSUs, and all transactions were carried out under a Rule 10b5-1 trading plan adopted June 9, 2025 and modified September 10, 2025.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Brophy Michael Burkes
Role CHIEF FINANCIAL OFFICER
Sold 5,064 shs ($1.28M)
Type Security Shares Price Value
Sale Common Stock F4 1,863 $249.38 $465K
Sale Common Stock F2, F3 1,241 $254.0705 $315K
Sale Common Stock F4, F5 1,008 $253.7672 $256K
Sale Common Stock F4, F6 170 $254.3338 $43K
Sale Common Stock F1 782 $260.4908 $204K
Holdings After Transaction: Common Stock — 52,432 shares (Direct)
Footnotes (6)
  1. F1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units ("RSUs") and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024.
  2. F2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.
  3. F3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.0696 to $254.3500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.
  5. F5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.32 to $254.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.32 to $254.3550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Total shares sold 5,064 shares Aggregate common stock sales by CFO Brophy Michael Burkes on July 27–29, 2026
July 27, 2026 sale 782 shares at $260.4908 per share Open-market sale of Natera, Inc. common stock with tax-withholding purpose
July 28, 2026 sale (block 1) 1,241 shares at $254.0705 per share Weighted average price; trades ranged from $254.0696 to $254.3500 per share
July 28, 2026 sale (block 2) 1,008 shares at $253.7672 per share Weighted average price; trades ranged from $253.32 to $254.25 per share
July 28, 2026 sale (block 3) 170 shares at $254.3338 per share Weighted average price; trades ranged from $254.32 to $254.3550 per share
July 29, 2026 sale 1,863 shares at $249.3800 per share Open-market sale of Natera, Inc. common stock under 10b5-1 plan
Trading plan adoption date June 9, 2025 Adoption of Rule 10b5-1 trading plan covering the reported sales
Trading plan modification date September 10, 2025 Modification date of the CFO’s Rule 10b5-1 trading plan
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Restricted Stock Units ("RSUs") financial
"obligations in connection with the vesting of Restricted Stock Units ("RSUs")"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
weighted average price financial
"The reported price in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
tax withholding and remittance obligations financial
"effected in order to satisfy tax withholding and remittance obligations in connection"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider stock activity did Natera (NTRA) disclose for its CFO?
Natera disclosed that CFO Brophy Michael Burkes sold 5,064 shares of common stock on July 27–29, 2026. The transactions were reported as open-market sales, with some tied to RSU-related tax withholding and all executed under a Rule 10b5-1 trading plan.

How many Natera (NTRA) shares did CFO Brophy Michael Burkes sell?
CFO Brophy Michael Burkes sold a total of 5,064 Natera common shares across five transactions. These trades occurred on July 27, 28 and 29, 2026, with individual block sizes ranging from 170 shares to 1,863 shares.

Were Natera (NTRA) CFO stock sales made under a Rule 10b5-1 plan?
Yes. All reported sales were effected under a Rule 10b5-1 trading plan for the CFO. The plan was adopted on June 9, 2025 and later modified on September 10, 2025, as disclosed in the transaction footnotes.

Did any Natera (NTRA) insider sales relate to RSU tax withholding?
Yes. Some sales were specifically to satisfy tax withholding and remittance obligations tied to vesting Restricted Stock Units (RSUs). These RSUs were granted under stock unit agreements dated January 27, 2023 and January 26, 2024, according to the footnotes.

At what prices did the Natera (NTRA) CFO sell shares in late July 2026?
Reported per-share prices include $260.4908, $254.0705, $253.7672, $254.3338 and $249.3800. Several prices are disclosed as weighted average prices, with trades executed within specified price ranges noted in the footnotes.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Brophy Michael Burkes
(Last)(First)(Middle)
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
(Street)
AUSTIN TEXAS 78753
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Natera, Inc. [ NTRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CHIEF FINANCIAL OFFICER
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/27/2026S782(1)D$260.490856,714D
Common Stock07/28/2026S1,241(2)D$254.0705(3)55,473D
Common Stock07/28/2026S1,008(4)D$253.7672(5)54,465D
Common Stock07/28/2026S170(4)D$254.3338(6)54,295D
Common Stock07/29/2026S1,863(4)D$249.3852,432D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units ("RSUs") and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024.
2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.
3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.0696 to $254.3500 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as modified on September 10, 2025.
5. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.32 to $254.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $254.32 to $254.3550 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact07/29/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR